Largest Urology Meeting in the World To Include Physician-Scientists From NewYork-Presbyterian Hospital
Experts in Sexual Dysfunction, Infertility, Prostate Cancer, Incontinence, Pediatric Urology, Minimally Invasive Treatments, and More
May 7, 2004
New York, NY
The American Urological Association (AUA)'s Annual Meeting is the largest meeting of urologic professionals in the world. With more than 10,000 urologists and health-care professionals and 5,000 exhibitors in attendance, the AUA Meeting, to be held May 8-13, 2004, in San Francisco, California, will highlight the latest advances in urology.
NewYork-Presbyterian Hospital's Urology Department is ranked one of the top ten centers in the country by US News World Report. Experts from NewYork-Presbyterian will discuss the newest findings and standards of care in urological disease.
Medical Experts who will present at the AUA meeting include:
Dr. Jerry Blaivas will present in several areas: a Panel Discussion on Voiding Dysfunction After Incontinence Surgery; a Podium Session on enterocystoplasty and continent diversion in patients with benign urologic disorders; a Discussed Poster on a new overactive bladder questionnaire and symptom score; and a second Podium Session on overactive bladder and the characteristics of mixed versus simple urge incontinence.
Dr. Diane Felsen will discuss Take Home Messages: Basic Science.
Dr. Harry Fisch will present the AUA Update and discuss Defining the Standard for Vasectomy Success.
Dr. Kenneth I. Glassberg, an expert in pediatric urology, will chair lectures exploring The Molecular Basis of Congenital Genitourinary Anomalies and Gender Reassignment: Yea or Nay.
Dr. Steven A. Kaplan will give an update on Medical Management of Benign Prostatic Hypertrophy (BPH), including the benefits and risks of current medical therapies; various minimally invasive technologies to treat BPH; the cost-to-benefit ratio of these therapies in BPH; future basic science and clinical initiatives in BPH; and the potential impact on both urologic practice and patient care. Dr. Kaplan will also present on Sexual Function in Ethnically Diverse Men, The Genetic Linkage Between Panic Disorder and Interstitial Cystitis, and High Power KTP Photoselective Laser Vaporization Prostatectomy in Men with Large Prostates.
Dr. Aaron Katz will discuss salvage cryotherapy treatment for prostate cancer.
Dr. Carl A. Olsson, chair of urology at NewYork-Presbyterian/Columbia and AUA Secretary, will provide an introduction and welcome at the plenary session.
Dr. Daniel Petrylak will discuss Targeted Therapies for Prostate Cancer, including clinical trials to evaluate new targets for the treatment of hormone-refractory disease and hormone-naive prostate cancer.
Dr. Ridwan Shabsigh, an expert in sexual function and dysfunction, will lead panel discussions on Androgen Replacement in the Aging Male and How to Manage RT Failures in Prostrate Cancer.
Dr. E. Darracott Vaughan, in an AUA Update: Report of the IOM Study on Assessing the Need for Clinical Trials of Testosterone Treatment, will present a summary of the recent Institute of Medicine (IOM) report on testosterone and aging. The report suggests that further research continue to establish the efficacy of testosterone replacement in men over 65.